🔗 Share this article

Chancellor Reeves has announced she is planning "specific action to deal with cost of living pressures" in next month's financial statement.

In comments to media outlets, she noted that lowering inflation is a joint duty of both the government and the Bank of England.

The United Kingdom's price growth is expected to be the most elevated among the G7 industrialized countries this year and the following year.

Potential Utility Bill Measures

It is understood the administration could take action to lower utility costs, such as by slashing the present 5% level of value-added tax charged on energy.

Another approach is to cut some of the policy costs currently included in household expenses.

Fiscal Limitations and Expert Predictions

The government will obtain the next report from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much scope there is for these actions.

The expectation from most economists is that the Chancellor will have to declare higher taxes or spending cuts in order to adhere to her voluntary fiscal targets.

Previously on the same day, estimates showed there was a twenty-two billion pound gap for the Treasury chief to address, which is at the more modest range of forecasts.

"There's a collective responsibility between the central bank and the administration to bear down further on some of the causes of price increases," Reeves told reporters in Washington, at the annual meetings of the IMF and World Bank.

Tax Pledges and Global Concerns

While a great deal of the focus has been on probable tax rises, the Treasury chief said the latest figures from the fiscal watchdog had not altered her pledge to manifesto promises not to increase rates on earnings tax, VAT or National Insurance.

She attributed an "uncertain world" with rising geopolitical and commercial tensions for the fiscal tax moves, probably to be directed on those "with the broadest shoulders."

International Trade Tensions

Commenting on worries about the United Kingdom's economic relations with China she said: "Our security interests always are paramount."

Recent statement by Chinese authorities to tighten trade restrictions on rare earths and other resources that are crucial for high-technology manufacturing led US President Donald Trump to threaten an extra 100% tariff on imports from the Asian country, raising the risk of an full-scale trade war between the two largest economies.

The American finance chief labeled China's action "economic coercion" and "a international production power grab."

Inquired about accepting the US offer to participate in its conflict with China, Reeves said she was "very concerned" by Chinese measures and encouraged the Beijing authorities "to avoid restrictions and restrict access."

She said the action was "bad for the global economy and causes further challenges."

"It is my opinion there are fields where we need to confront Chinese policies, but there are also valuable opportunities to export to Chinese markets, including banking sector and other sectors of the economy. We've got to get that balance appropriate."

The Treasury chief also confirmed she was cooperating with international partners "on our own critical minerals plan, so that we are more independent."

NHS Medicine Costs and Funding

Reeves also admitted that the cost the National Health Service pays for pharmaceuticals could increase as a consequence of current negotiations with the US government and its drugs companies, in return for reduced taxes and investment.

Some of the world's largest pharmaceutical manufacturers have said lately that they are either delaying or abandoning projects in the UK, with some attributing the low prices they are receiving.

Last month, the Science Minister said the price the NHS spends on medicines would have to go up to halt businesses and drug research funding leaving the UK.

The Chancellor informed the BBC: "It has been observed because of the cost structure, that drug testing, new drugs have not been provided in the UK in the manner that they are in other EU nations."

"The objective is to make sure that patients receiving treatment from the National Health Service are can receive the top essential treatments in the globe. And so we are looking at all of that, and... aiming to obtain additional funding into the UK."